NeuroOne Medical Technologies (NMTC) - 2019 Q1 - Quarterly Report

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended December 31, 2018 -OR- ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transaction period from _________ to________ Commission File Number: 000-54716 NeuroOne Medical Technologies Corporation (Exact name of Registrant as specified in its charter) | Delaware | 27-0863354 | ...